Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 4.50 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2022-03-30
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2020 was 4.50M shares, a 169.30% increase from fiscal 2019.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2019 was 1.67M shares, a 120.45% increase from fiscal 2018.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2018 was 758.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month as first filed |
|---|---|---|
| 2020-12-31 | 4.50M shares 10-K · filed 2022-03-30 | 2.21M shares 10-K · filed 2021-03-26 |
| 2019-12-31 | 1.67M shares 10-K · filed 2020-03-30 | |
| 2018-12-31 | 758.00K shares 10-K · filed 2019-03-07 |